Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
CNBC: Crypto organizations urge US lawmakers to advance legislation quickly after reaching a landmark agreement

CNBC: Crypto organizations urge US lawmakers to advance legislation quickly after reaching a landmark agreement

BlockBeatsBlockBeats2026/05/05 01:57
Show original

BlockBeats news, May 5, according to CNBC, several crypto companies, including a certain exchange, are urging the US Congress to advance an important market structure bill—the CLARITY Act—as early as next week. Previously, senators unveiled a compromise provision aimed at resolving disputes between the banking sector and the crypto industry regarding when stablecoins can offer yield rewards.


The proposal, put forward by Senators Thom Tillis and Angela Alsobrooks, would prohibit crypto companies from offering yield-like rewards to holders of stablecoins. Banks have warned that such incentives could lead to a decrease in deposits, thereby undermining their lending capacity. However, the proposal allows rewards to be offered when users spend or use stablecoins.


This "regulatory framework" style crypto bill is the industry's top legislative priority, and the Trump administration is actively pushing for its passage. The intense debate over stablecoins is seen as one of the main obstacles to the bill's progress in the Senate Banking Committee, though other disagreements remain.


The crypto industry as a whole welcomes the text. A certain exchange CEO, Brian Armstrong, posted on X, stating that the committee should promptly "enter the markup stage" (that is, hold a vote in the Senate Banking Committee).


Currently, the Senate Banking Committee has not yet announced the first voting time for the bill. Committee Chairman Tim Scott stated on X on Monday that the committee "is close to reaching a consensus and is committed to conducting a bipartisan markup vote in May."

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

After Eli Lilly's nearly 300% surge in four years, Wall Street remains bullish: The "hidden pipeline" beyond GLP-1 is underestimated

Eli Lilly’s share price has surged nearly 300% since the approval of its first GLP-1 drug, with its market capitalization surpassing 1 trillion USD, yet Wall Street remains optimistic about its continued growth. Berenberg has upgraded Eli Lilly’s rating to “Buy," believing that Mounjaro and Zepbound will continue to see strong volume, and that the oral GLP-1 drug could further drive demand. Additionally, Eli Lilly continues to expand into areas such as cancer and sleep disorders, and the potential of its non-obesity-related pipelines remains underestimated by the market.

华尔街见闻2026/09/18 13:21